一个SITC的愿景:调整临床试验以加速癌症免疫疗法药物开发
Thomas U Marron1, Jason J Luke2, Brianna Hoffner3
1Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Journal for immunotherapy of cancer
|March 22, 2025
概括
癌症免疫疗法 (IO) 临床试验需要超越传统化疗模式的新策略. 根据新的终点和数据科学调整试验设计,对于开发有效的基于免疫的癌症治疗来说至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 临床试验设计 临床试验设计
背景情况:
- 设计用于化疗的传统临床试验范式对于新型癌症免疫疗法 (IO) 不够.
- 最近IO的进展,包括工程T细胞和瘤透淋巴细胞,突出了对自适应性药物开发策略的需求.
- 由于IO的独特反应模式,需要重新评估进展标准和试验终点.
研究的目的:
- 概述癌症免疫治疗药物开发的不断变化的格局.
- 强调需要将临床试验设计适应IO的独特特征.
- 突出加速IO批准的新兴机遇和挑战.
主要方法:
- 审查癌症免疫治疗临床试验当前的趋势和创新.
- 分析监管机构 (如美国FDA) 对试验设计的影响.
- 讨论新的终点,数据科学和以患者为中心的方法.
主要成果:
- IO药物开发需要从基于化疗的模型转变范式.
- 创新包括"活药" (例如,工程T细胞) 和实时制造.
- 新的终点 (例如,病理反应,无治疗生存) 和患者报告的结果正在获得接受.
- 数据科学,人工智能和精简的研究生态系统是加速IO发展的关键.
- 癌症免疫疗法协会 (SITC) 的目标是在10年内获得100个新的IO批准.
结论:
- 调整临床试验设计对于充分利用癌症免疫疗法的全部潜力至关重要.
- 整合生物标志物,新辅助剂设置和患者报告的结果将改善IO疗效测量.
- 合作努力和创新方法对于实现SITC的目标,即广泛应用IO用于癌症治疗和预防至关重要.
相关概念视频
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Cancer Vaccines
313
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
313
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


